How Erlander was paid
$3M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Options | Incentive | Total |
|---|---|---|---|---|
| Mark ErlanderCEO | $635,000 | $2,266,106 | $122,238 | $3,023,344 |
| James LevineCFO | $490,000 | $993,875 | $61,740 | $1,545,615 |
| Roger SidhuCMO | $279,370 | $1,920,275 | $74,160 | $2,273,805 |
What changed and why
- $3MMark Erlander received total compensation of $3,023,344 in fiscal 2025, an increase from $2,401,376 in 2024.
- 55%Mark Erlander's base salary was $635,000, and he was eligible for an annual cash bonus of up to 55% of base salary.
- $515KRoger Sidhu joined the company as Chief Medical Officer in June 2025 with a base compensation of $515,000.
- $3.86Roger Sidhu received a new-hire inducement grant of 600,000 non-qualified stock options with an exercise price of $3.86.
- $490KJames Levine served as CFO with a base compensation of $490,000 and received total compensation of $1,545,615 in 2025.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.